SCHEMBL23219216

SCHEMBL23219216

c1cc2ccc3occc3c2[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.42
MAOB P27338 3/20 0.42
NFKB1 P19838 1/20 0.42
TNF P01375 1/20 0.37
RIPK1 Q13546 1/20 0.37
HTR2C P28335 3/20 0.36
HTR2A P28223 2/20 0.36
HTR2B P41595 1/20 0.36
AHR P35869 1/20 0.35
PIM3 Q86V86 1/20 0.33
PAX8 Q06710 1/20 0.32
BRD4 O60885 1/20 0.32
TAF1 P21675 1/20 0.32
BRPF1 P55201 1/20 0.32
CREBBP Q92793 1/20 0.32
CECR2 Q9BXF3 1/20 0.32
BRD9 Q9H8M2 1/20 0.32
KEAP1 Q14145 1/20 0.32
FTO Q9C0B1 1/20 0.31
PDPK1 O15530 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29591435 1.00 MAOA (0.42) MAOAMAOBNFKB1TNFRIPK1
SCHEMBL1160167 0.73 MAOA (0.47) MAOAMAOBNFKB1HTR2CHTR2A
SCHEMBL4923157 0.72 MAOA (0.49) MAOAMAOBNFKB1BRD4TAF1
SCHEMBL4420813 0.72 DYRK1A (0.31)
SCHEMBL4426880 0.71 TNF (0.39) MAOAMAOBTNFRIPK1HTR2C
SCHEMBL4419365 0.71 ALDH1A1 (0.42) FTO
SCHEMBL4429415 0.69 PAX8 (0.48) MAOAMAOBNFKB1HTR2CHTR2A
SCHEMBL29591462 0.69 TNF (0.54) TNFRIPK1AHRPIM3BRD4
SCHEMBL1374474 0.69 TNF (0.54) TNFRIPK1AHRPIM3BRD4
SCHEMBL4420524 0.69 HTR2C (0.37) MAOAMAOBNFKB1HTR2CHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed